siRNA, Anti-NAT2, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01004WQ-2OMe)

The product SIRGT01004WQ-2OMe is a type of small interfering RNA (siRNA) that targets NAT2 gene and regulates the expression of gene. The siRNA interferes with the expression of NAT2 genes with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_000015.2
Alternative Names AAC2; PNAT; NAT-2
Related Diseases Bladder cancer, Breast cancer
Purification HPLC
Target Gene
Gene ID 10
Uniprot ID P11245
Sub Cat Target Species Modification Scale  
SIRGT02004WQ-2F NAT2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT03004WQ-2MOE NAT2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04004WQ-LNA NAT2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01004WQ-RB NAT2 Human Ribo-modified Inquiry
SIRGT02004WQ-BB NAT2 Human Backbone-modified Inquiry

Related Products